WIN-Partners Co., Ltd.
3183
Rank in Stocks
#16248
Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd.... Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include cutting-edge cardiovascular tools such as percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters. The company also supplies devices for cardiac rhythm management, like pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters. Furthermore, WIN-Partners provides structural and peripheral vascular products, including stent grafts, transcatheter heart valves, mechanical heart valves, and various stents and embolic coils. Rounding out its portfolio are diabetes management systems such as insulin pumps and continuous glucose monitoring devices, in addition to magnetic resonance imaging equipment.
Share Price
$7.98
Last synced: 2026-11-10
Market Cap
$219.31M
Change (1 day)
-0.79%
Change (1 year)
-4.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade WIN-Partners Co., Ltd. (3183)
Category
Healthcare
EPS for WIN-Partners Co., Ltd. (3183)
EPS as of September 2026 TTM: $0.57
According to WIN-Partners Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.57. At the end of 2025 the company had an EPS of $0.47, an increase over its 2024 EPS of $0.43.
EPS history for WIN-Partners Co., Ltd. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.57 | 22.28% |
| 2025 | $0.47 | 10.46% |
| 2024 | $0.43 | -21.58% |
| 2023 | $0.54 | 3.43% |
| 2022 | $0.52 | 8.28% |
| 2021 | $0.48 | -20.14% |
| 2020 | $0.61 | -26.79% |
| 2019 | $0.83 | -15.89% |
| 2018 | $0.99 | 47.15% |
| 2017 | $0.67 | 2.42% |
| 2016 | $0.65 | 33.21% |
| 2015 | $0.49 | -21.02% |
| 2014 | $0.62 | 48.84% |
| 2013 | $0.42 | -11.45% |
| 2012 | $0.47 | 12.61% |
| 2011 | $0.42 | 6.70% |
| 2010 | $0.39 | -98.82% |
| 2009 | $33.13 | 8,830.27% |
| 2008 | $0.37 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | 6,694.85% |
US
|
|
| $17.99 | 3,030.33% |
US
|
|
| $7.77 | 1,252.01% |
US
|
|
| $17.99 | 3,030.33% |
US
|
|
| $0.04 | -92.43% |
AU
|
Questions about WIN-Partners Co., Ltd.'s earnings per share (EPS)
What is WIN-Partners Co., Ltd.'s earnings per share (EPS)?
WIN-Partners Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.57, as of Sep 2026.
What was WIN-Partners Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, WIN-Partners Co., Ltd.'s earnings per share (EPS) was $0.47, 9.30% more than in 2024 ($0.43).
How has WIN-Partners Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, WIN-Partners Co., Ltd.'s earnings per share (EPS) went from $0.61 to $0.47, an average decline of 5.08% a year.
How does WIN-Partners Co., Ltd.'s earnings per share (EPS) compare with similar companies?
WIN-Partners Co., Ltd.'s earnings per share (EPS) ($0.57) is higher than that of 1 of the 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.